Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a prospective study investigating the relationship between vitamin D and peripheral neuropathy (PN) among multiple myeloma (MM) patients treated with either bortezomib or thalidomide. The study consists of a screening period of up to 14 days, followed by a single assessment visit to evaluate vitamin D levels, incidence and severity of PN, neuropathic pain, and markers of depression. Patient charts will also be utilized to assess the frequency of skeletal-related events.
Epistemonikos ID: b9f8eabf6b8080ada023ef288d373d0a6346c52f
First added on: May 11, 2024